Karleen Girn

Post-Market Drug Evaluation Program, Canada’s Drug Agency (CDA), Canada

Poster(s):

• (B-060) Opioid Agonist Treatment Dispensing Trends Between 2018 and 2022 Across Six Canadian Provinces
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET